205 related articles for article (PubMed ID: 24194259)
21. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
[TBL] [Abstract][Full Text] [Related]
22. Racial differences in premenopausal endogenous hormones.
Pinheiro SP; Holmes MD; Pollak MN; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2147-53. PubMed ID: 16172224
[TBL] [Abstract][Full Text] [Related]
23. Location-dependent ethnic differences in the risk of colorectal adenoma: a retrospective multiethnic study.
Zheng XE; Li T; Lipka S; Levine E; Vlacancich R; Takeshige U; Mustacchia P; Multz A; Gotlieb V
J Clin Gastroenterol; 2014 Jan; 48(1):e1-7. PubMed ID: 23426462
[TBL] [Abstract][Full Text] [Related]
24. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
[TBL] [Abstract][Full Text] [Related]
25. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population.
Ognjanovic S; Yamamoto J; Saltzman B; Franke A; Ognjanovic M; Yokochi L; Vogt T; Decker R; Le Marchand L
Cancer Causes Control; 2010 Jul; 21(7):1131-8. PubMed ID: 20333461
[TBL] [Abstract][Full Text] [Related]
26. IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.
Hoyo C; Murphy SK; Schildkraut JM; Vidal AC; Skaar D; Millikan RC; Galanko J; Sandler RS; Jirtle R; Keku T
Dis Markers; 2012; 32(2):133-41. PubMed ID: 22377707
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.
Flood A; Mai V; Pfeiffer R; Kahle L; Rosen CJ; Lanza E; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1493-8. PubMed ID: 18559566
[TBL] [Abstract][Full Text] [Related]
28. IGF-I levels and visceral fat accumulation in colonic neoplasia.
Erarslan E; Coşkun Y; Türkay C; Köktener A; Aydoğan T
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):99-105. PubMed ID: 23954111
[TBL] [Abstract][Full Text] [Related]
29. Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration.
Chiu CJ; Conley YP; Gorin MB; Gensler G; Lai CQ; Shang F; Taylor A
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9099-107. PubMed ID: 22058336
[TBL] [Abstract][Full Text] [Related]
30. Reducing racial disparity in colorectal cancer burden.
Laiyemo AO
Dig Dis Sci; 2014 Sep; 59(9):2025-7. PubMed ID: 25056764
[No Abstract] [Full Text] [Related]
31. Racial differences in measures of obesity and risk of colon adenoma.
Thompson CL; Berger NA; Chak A; Li L
Obesity (Silver Spring); 2012 Mar; 20(3):673-7. PubMed ID: 21996657
[TBL] [Abstract][Full Text] [Related]
32. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
33. High-risk colorectal adenomas and serum insulin-like growth factors.
Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
[TBL] [Abstract][Full Text] [Related]
34. Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.
Rutter CM; Knudsen AB; Lin JS; Bouskill KE
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):3-12. PubMed ID: 33144285
[TBL] [Abstract][Full Text] [Related]
35. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
[TBL] [Abstract][Full Text] [Related]
36. Association of a common polymorphism in the human GH1 gene with colorectal neoplasia.
Le Marchand L; Donlon T; Seifried A; Kaaks R; Rinaldi S; Wilkens LR
J Natl Cancer Inst; 2002 Mar; 94(6):454-60. PubMed ID: 11904318
[TBL] [Abstract][Full Text] [Related]
37. Genetic ancestry is associated with colorectal adenomas and adenocarcinomas in Latino populations.
Hernandez-Suarez G; Sanabria MC; Serrano M; Herran OF; Perez J; Plata JL; Zabaleta J; Tenesa A
Eur J Hum Genet; 2014 Oct; 22(10):1208-16. PubMed ID: 24518838
[TBL] [Abstract][Full Text] [Related]
38. Commentary: risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients.
Collins PD
Aliment Pharmacol Ther; 2012 Aug; 36(3):290. PubMed ID: 22747450
[No Abstract] [Full Text] [Related]
39. Insulin-like growth factor polymorphisms and colorectal cancer risk.
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1204-11. PubMed ID: 15894673
[TBL] [Abstract][Full Text] [Related]
40. Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population.
Stein B; Anderson JC; Rajapakse R; Alpern ZA; Messina CR; Walker G
Dig Dis Sci; 2010 Oct; 55(10):2945-52. PubMed ID: 20112063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
